001     275833
005     20250119000333.0
024 7 _ |a 10.1101/2024.12.16.628673
|2 doi
024 7 _ |a altmetric:172155388
|2 altmetric
024 7 _ |a pmid:39763884
|2 pmid
037 _ _ |a DZNE-2025-00068
100 1 _ |a Fink, Ryan
|0 0009-0001-2661-5586
|b 0
245 _ _ |a PinkyCaMP a mScarlet-based calcium sensor with exceptional brightness, photostability, and multiplexing capabilities
260 _ _ |c 2024
336 7 _ |a Preprint
|b preprint
|m preprint
|0 PUB:(DE-HGF)25
|s 1736941433_13620
|2 PUB:(DE-HGF)
336 7 _ |a WORKING_PAPER
|2 ORCID
336 7 _ |a Electronic Article
|0 28
|2 EndNote
336 7 _ |a preprint
|2 DRIVER
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a Output Types/Working Paper
|2 DataCite
520 _ _ |a Genetically encoded calcium (Ca2+) indicators (GECIs) are widely used for imaging neuronal activity, yet current limitations of existing red fluorescent GECIs have constrained their applicability. The inherently dim fluorescence and low signal-to-noise ratio of red-shifted GECIs have posed significant challenges. More critically, several red-fluorescent GECIs exhibit photoswitching when exposed to blue light, thereby limiting their applicability in all-optical experimental approaches. Here, we present the development of PinkyCaMP, the first mScarlet-based Ca2+ sensor that outperforms current red fluorescent sensors in brightness, photostability, signal-to-noise ratio, and compatibility with optogenetics and neurotransmitter imaging. PinkyCaMP is well-tolerated by neurons, showing no toxicity or aggregation, both in vitro and in vivo. All imaging approaches, including single-photon excitation methods such as fiber photometry, widefield imaging, miniscope imaging, as well as two-photon imaging in awake mice, are fully compatible with PinkyCaMP.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef
700 1 _ |a Imai, Shosei
|0 0000-0003-0388-4764
|b 1
700 1 _ |a Gockel, Nala
|0 P:(DE-2719)9002002
|b 2
700 1 _ |a Lauer, German
|0 0000-0002-4588-2743
|b 3
700 1 _ |a Renken, Kim
|0 0009-0004-4644-7673
|b 4
700 1 _ |a Wietek, Jonas
|0 0000-0002-8079-7042
|b 5
700 1 _ |a Lamothe-Molina, Paul J
|0 0000-0002-7793-5133
|b 6
700 1 _ |a Furhmann, Falko
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Mittag, Manuel
|0 P:(DE-2719)2811044
|b 8
700 1 _ |a Ziebarth, Tim
|0 P:(DE-HGF)0
|b 9
700 1 _ |a Canziani, Annika
|0 0009-0006-4051-8615
|b 10
700 1 _ |a Kubitschke, Martin
|0 0009-0009-1212-0361
|b 11
700 1 _ |a Kistmacher, Vivien
|0 P:(DE-HGF)0
|b 12
700 1 _ |a Kretschmer, Anny
|0 P:(DE-2719)2810979
|b 13
700 1 _ |a Sebastian, Eva
|0 P:(DE-2719)9002055
|b 14
700 1 _ |a Schmitz, Dietmar
|0 P:(DE-2719)2810725
|b 15
|u dzne
700 1 _ |a Terai, Takuya
|0 0000-0002-3425-3589
|b 16
700 1 _ |a Gründemann, Jan
|0 P:(DE-2719)9001219
|b 17
700 1 _ |a Hassan, Sami
|0 0000-0002-8784-143X
|b 18
700 1 _ |a Patriarchi, Tommaso
|0 0000-0001-9351-3734
|b 19
700 1 _ |a Reiner, Andreas
|0 0000-0003-0802-7278
|b 20
700 1 _ |a Fuhrmann, Martin
|0 P:(DE-2719)2679991
|b 21
700 1 _ |a Campbell, Robert E
|0 0000-0003-0604-092X
|b 22
700 1 _ |a Masseck, Olivia A
|0 0000-0002-1541-2388
|b 23
773 _ _ |a 10.1101/2024.12.16.628673
|y 2024
|t bioRxiv
909 C O |o oai:pub.dzne.de:275833
|p VDB
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9002002
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-HGF)0
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2811044
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 13
|6 P:(DE-2719)2810979
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)9002055
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 15
|6 P:(DE-2719)2810725
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)9001219
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2679991
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
920 1 _ |0 I:(DE-2719)5000069
|k AG Gründemann
|l Neural Circuit Computations
|x 0
920 1 _ |0 I:(DE-2719)1011004
|k AG Fuhrmann
|l Neuroimmunology and Imaging
|x 1
920 1 _ |0 I:(DE-2719)1810004
|k AG Schmitz
|l Network Dysfunction
|x 2
980 _ _ |a preprint
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000069
980 _ _ |a I:(DE-2719)1011004
980 _ _ |a I:(DE-2719)1810004
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21